Katja Akgun
Dresden, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 104 publications
Neurofilament light chain as a tool for assessing disease activity and treatment response in Multiple Sclerosis
Journal: Fortschritte der Neurologie-Psychiatrie
Published: July 13, 2026
From measurement to biomarker trajectories: platform-agnostic Z score analysis of serum NfL and GFAP in ocrelizumab-treated multiple sclerosis.
Journal: Journal of neurology
Published: March 23, 2026
Beyond B Cell Depletion: Adhesion and Activation Network Remodeling During Repeated Intravenous Anti-CD20 Therapy in Multiple Sclerosis.
Journal: Neurology and therapy
Published: February 21, 2026
Beyond the interferon score: neurofilament light chain and glial fibrillary acidic protein capture immune-mediated neuroinjury and response to JAK inhibition in Aicardi-Goutières syndrome.
Journal: Frontiers in immunology
Published: January 06, 2026
Elevated neurofilament light levels in acute anorexia nervosa are associated with alterations in white matter volume and connectivity networks.
Journal: Journal of child psychology and psychiatry, and allied disciplines
Published: October 10, 2025
Longitudinal high-frequency blood biomarkers of axonal injury and astrocytic activation after immune reconstitution in multiple sclerosis.
Journal: Journal of neuroinflammation
Published: September 28, 2025
Machine learning integration of MRI and gait reveals mobility phenotypes in multiple sclerosis.
Journal: Brain communications
Published: July 02, 2025
Extensive T-Cell Profiling Following SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs.
Journal: Pathogens (Basel, Switzerland)
Published: February 07, 2025
Challenges and implications of anti-JCV antibody serology variability among different assays in natalizumab treatment: A call for standardization and transparency in clinical practice.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: November 23, 2024
Variations in neuronal cytoskeletal integrity affect directed communication in distributed networks during inhibitory control.
Journal: Communications biology
Published: October 15, 2024
Cost-consequence analysis of early vs. delayed natalizumab use in highly active relapsing-remitting multiple sclerosis: a simulation study.
Journal: Journal of neurology
Published: October 11, 2024
Integrating large language models in care, research, and education in multiple sclerosis management.
Integrating large language models in care, research, and education in multiple sclerosis management.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 23, 2024
Last Updated: 09/26/2026